Re: Duchene muscular dystrophy

From: Allen Gardner (allen.gardner@utoronto.ca)
Wed Nov 6 19:35:06 1996


I suggest that before embarking on fetal muscle biopsy that the sex of the fetus be determined. If it's a girl, she will not be a "patient". If a male, then you can approach the patient about muscle biopsy. Perhaps someone can tell me how reliable the dystrophin staining is in predicting DMD in a fetus. Allen.

--
Allen Gardner MD
Genetics
Oshawa General Hospital
Oshawa, Ontario, Canada
====================================================
> If your patient wants the fetus checked testing by muscle biopsy is
available
> if DNA analysis would not be diagnostic. For DNA testing I would
suggest
> someplace like Baylor or Integrated Genetics. Muscle biopsy has
been performed
> multiple times at UCSF, Detroit, and we could do it. Testing of the
muscle
> biopsy by histology and staining for dystrophin has traditionally
been done in
> the Hoffman lab (I believe in Pennsylvania) but there may be others
performing
> it now.
>
> I have probably overburdened you with details but let me know if
this helps or
> you need more info. I'm sure you will hear from others.
>
> Jerome Yankowitz, MD
> Univ of Iowa Hosp and Clinics
> Maternal-Fetal Medicine and Clinical Genetics




use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Wed Dec 2 05:17:41 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.